Related Experiment Videos
Implementation of locally adapted guidelines on type 2 diabetes
Rykel van Bruggen1, Kees J Gorter, Roland P Stolk
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The netherlands. j.a.r.vanbruggen@umcutrecht.nl
Family Practice
|August 23, 2008
Summary
Implementing adapted shared care guidelines for type 2 diabetes improved care processes but did not significantly reduce cardiovascular risks in the short term. Further research is needed for long-term impacts.
Area of Science:
- Clinical Medicine
- Diabetes Care
- Health Services Research
Background:
- Type 2 diabetes management requires effective shared care guidelines.
- Facilitator-enhanced interventions can improve guideline implementation.
- Local adaptation of guidelines may enhance relevance and uptake.
Purpose of the Study:
- To evaluate a multifaceted intervention for implementing a locally adapted shared care guideline for type 2 diabetes.
- To assess the impact of this intervention on diabetes care processes and intermediate outcomes.
Main Methods:
- A 1-year cluster-randomized trial involving 30 general practices.
- Intervention group: Nurse facilitators guided implementation (barrier analysis, structured care, training, feedback).
- Control group: General practitioners (GPs) continued usual care. Generalized estimating equations were used for analysis.
Main Results:
- Intervention group showed increased 3-monthly patient reviews (88% vs. 69%) and more frequent blood pressure (83% vs. 66%) and bodyweight (78.9% vs. 48.5%) measurements.
- No significant differences were observed in HbA1c%, blood pressure, body mass index, or treatment satisfaction between groups.
- A marginal difference in mean cholesterol was noted.
Conclusions:
- The multifaceted intervention successfully improved the process of diabetes care delivery.
- However, the intervention did not significantly alter intermediate clinical outcomes in the short term.
- Local adaptation of shared care guidelines for type 2 diabetes does not appear to reduce short-term cardiovascular risks.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.